NEU Ann: Neuren commences Phase 2 trials of NNZ-2591 in PMS and PTHS - 8th Aug 2022, 9:14am

annb0t

annb0t

Top 20
NEU Ann: Neuren commences Phase 2 trials of NNZ-2591 in PMS and PTHS
Price Sensitive: Y
Date: 8th Aug 2022, 9:14am

>>> Read announcement: Google: NEU Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
NEU Ann: Neuren reports 2023 half-year profit after tax of $48m - 28th Aug 2023, 9:28am
Replies
0
Views
71
annb0t
annb0t
annb0t
NEU Ann: Neuren receives US$100m for expanded DAYBUE agreement - 27th Jul 2023, 11:16am
Replies
0
Views
84
annb0t
annb0t
annb0t
NEU Ann: Neuren and Acadia expand global partnership for trofinetide - 14th Jul 2023, 8:22am
Replies
0
Views
96
annb0t
annb0t
annb0t
NEU Ann: Neuren completes enrolment in Phelan-McDermid Phase 2 trial - 30th Jun 2023, 9:36am
Replies
0
Views
90
annb0t
annb0t
annb0t
NEU Ann: Neuren opens first site in US for Prader-Willi Phase 2 trial - 28th Jun 2023, 9:55am
Replies
0
Views
103
annb0t
annb0t
Top Bottom